Status:
NOT_YET_RECRUITING
Standardizing Right Hemicolectomy for Colon Cancer
Lead Sponsor:
Amsterdam UMC, location VUmc
Collaborating Sponsors:
Prof. dr. P.J. Tanis, colorectal surgeon
Dr. B.R. Toorenvliet, colorectal surgeon
Conditions:
Colonic Carcinoma
Laparoscopic Right Hemicolectomy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A surgical intervention might be highly variable amongst surgeons and centers. This variability has a potential relevance concerning clinical outcomes. For right-sided colon cancer, the laparoscopic ...
Detailed Description
1. Prospective mapping of current practice with surgical variations in laparoscopic right hemicolectomy (total duration of inclusion 3 months) N= 40 centers N = 310 videos 1. METC approval for the...
Eligibility Criteria
Inclusion
- Planned laparoscopic (extended) right hemicolectomy for colon cancer of the caecum, ascending colon or hepatic flexure;
- Age above 18 years;
- cTNM stage 1-3 (CT-staged);
- No prior midline or transverse laparotomy;
- ASA1-3;
- No immune modulating medication.
Exclusion
- cT4b;
- Perforated disease;
- Acute obstruction;
- Emergency operation;
- Appendiceal cancer;
- Other primary malignancy treated within 5 years from diagnosis of colon cancer, except for curatively treated prostate, breast, skin and cervical cancer.
Key Trial Info
Start Date :
July 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
930 Patients enrolled
Trial Details
Trial ID
NCT04889456
Start Date
July 1 2021
End Date
July 1 2027
Last Update
May 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amsterdam UMC, location VUmc
Amsterdam, North Holland, Netherlands, 1081 HV